Hepatocyte growth factor mediates mesenchymal stem cell–induced recovery in multiple sclerosis models

Mesenchymal stem cells (MSCs) have emerged as a potential therapy for a range of neural insults. In animal models of multiple sclerosis, an autoimmune disease that targets oligodendrocytes and myelin, treatment with human MSCs results in functional improvement that reflects both modulation of the immune response and myelin repair. Here we demonstrate that conditioned medium from human MSCs (MSC-CM) reduces functional deficits in mouse MOG35–55-induced experimental autoimmune encephalomyelitis (EAE) and promotes the development of oligodendrocytes and neurons. Functional assays identified hepatocyte growth factor (HGF) and its primary receptor cMet as critical in MSC-stimulated recovery in EAE, neural cell development and remyelination. Active MSC-CM contained HGF, and exogenously supplied HGF promoted recovery in EAE, whereas cMet and antibodies to HGF blocked the functional recovery mediated by HGF and MSC-CM. Systemic treatment with HGF markedly accelerated remyelination in lysolecithin-induced rat dorsal spinal cord lesions and in slice cultures. Together these data strongly implicate HGF in mediating MSC-stimulated functional recovery in animal models of multiple sclerosis.

[1]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[2]  J. Prineas,et al.  Pathology of Multiple Sclerosis , 2001 .

[3]  Thomas J. Boll,et al.  Handbook of clinical neuropsychology , 1981 .

[4]  J. Galipeau,et al.  Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  S. David,et al.  T cells contribute to lysophosphatidylcholine‐induced macrophage activation and demyelination in the CNS , 2007, Glia.

[6]  S. Miller,et al.  Human bone marrow‐derived mesenchymal stem cells induce Th2‐polarized immune response and promote endogenous repair in animal models of multiple sclerosis , 2009, Glia.

[7]  S. Watowich,et al.  Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation. , 2008, Biochemistry.

[8]  A. Caplan,et al.  Isolation of rat marrow-derived mesenchymal stem cells. , 2006, Experimental hematology.

[9]  T. Hoey,et al.  Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. , 2009, Neoplasia.

[10]  Angelo L. Vescovi,et al.  Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis , 2003, Nature.

[11]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[12]  E. Woo,et al.  A comparison of autologous and allogenic bone marrow-derived mesenchymal stem cell transplantation in canine spinal cord injury , 2009, Journal of the Neurological Sciences.

[13]  M. Aoki,et al.  Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. , 1996, Biochemical and biophysical research communications.

[14]  Antonio Uccelli,et al.  Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis , 2007, Annals of neurology.

[15]  T. Doyle,et al.  Hepatocyte Growth Factor or Vascular Endothelial Growth Factor Gene Transfer Maximizes Mesenchymal Stem Cell–Based Myocardial Salvage After Acute Myocardial Infarction , 2009, Circulation.

[16]  D. Karussis,et al.  The potential use of stem cells in multiple sclerosis: An overview of the preclinical experience , 2008, Clinical Neurology and Neurosurgery.

[17]  Robin J. M. Franklin,et al.  Remyelination in the CNS: from biology to therapy , 2008, Nature Reviews Neuroscience.

[18]  T. Ben-Hur,et al.  Prospects of Cell Therapy for Disorders of Myelin , 2008, Annals of the New York Academy of Sciences.

[19]  Soo-Yeol Lee,et al.  Mesenchymal stem cells promote proliferation of endogenous neural stem cells and survival of newborn cells in a rat stroke model , 2008, Experimental and Molecular Medicine.

[20]  E. Melamed,et al.  Intracerebroventricular Transplantation of Human Mesenchymal Stem Cells Induced to Secrete Neurotrophic Factors Attenuates Clinical Symptoms in a Mouse Model of Multiple Sclerosis , 2010, Journal of Molecular Neuroscience.

[21]  M. Noble,et al.  Identification of an adult-specific glial progenitor cell. , 1989, Development.

[22]  Andrea Bacigalupo,et al.  Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  C. Bernard,et al.  A Consensus Statement Addressing Mesenchymal Stem Cell Transplantation for Multiple Sclerosis: It’s Time! , 2010, Stem Cell Reviews and Reports.

[24]  C. Birchmeier,et al.  Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. , 1998, Trends in cell biology.

[25]  P. Comoglio,et al.  Selective expression of the Met/HGF receptor in human central nervous system microglia. , 1993, Oncogene.

[26]  P. Kondaiah,et al.  Gene expression profile of epithelial cells and mesenchymal cells derived from limbal explant culture , 2010, Molecular vision.

[27]  Toshikazu Nakamura,et al.  Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells , 2010, Proceedings of the National Academy of Sciences.

[28]  Robert H Miller,et al.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models , 2010, Disease Models & Mechanisms.

[29]  S. Gerson,et al.  Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH) , 2002, Bone Marrow Transplantation.

[30]  D. Meldrum,et al.  MEK , p 38 , and PI-3 K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells , 2009 .

[31]  Arnold I Caplan,et al.  Isolation of human marrow-derived mesenchymal stem cells. , 2006, Experimental hematology.

[32]  W. Pan,et al.  Permeation of hepatocyte growth factor across the blood–brain barrier , 2006, Experimental Neurology.

[33]  R. Miller,et al.  Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis , 2009, Experimental Neurology.

[34]  Woong Sun,et al.  Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. , 2002, Brain research. Molecular brain research.

[35]  K. Ohta,et al.  Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. , 2008, Life sciences.

[36]  A. Caplan,et al.  Human Mesenchymal Stem Cells Signals Regulate Neural Stem Cell Fate , 2007, Neurochemical Research.

[37]  Ludwin Sk,et al.  The neuropathology of multiple sclerosis. , 2000 .

[38]  S. Rivkees,et al.  Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells , 2002, Journal of neuroscience research.

[39]  G. Michalopoulos,et al.  Expression of HGF and cMet in the developing and adult brain. , 1997, Brain research. Developmental brain research.

[40]  K. Horn,et al.  Adult NG2+ Cells Are Permissive to Neurite Outgrowth and Stabilize Sensory Axons during Macrophage-Induced Axonal Dieback after Spinal Cord Injury , 2010, The Journal of Neuroscience.

[41]  J. Rubin,et al.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. , 1991, Science.

[42]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[43]  H. Okano,et al.  Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury , 2007, Journal of neuroscience research.

[44]  H. Yoshimatsu,et al.  Predictors for silent cerebral infarction in patients with chronic renal failure undergoing hemodialysis. , 2007, Metabolism: clinical and experimental.

[45]  K. Matsumoto,et al.  Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. , 2001, The Journal of clinical investigation.

[46]  A. Uccelli,et al.  Mesenchymal stem cells: a new strategy for immunosuppression? , 2007, Trends in immunology.

[47]  D. Meldrum,et al.  MEK, p38, and PI-3K mediate cross talk between EGFR and TNFR in enhancing hepatocyte growth factor production from human mesenchymal stem cells. , 2009, American journal of physiology. Cell physiology.

[48]  G. Michalopoulos.  Liver regeneration: molecular mechanisms of growth control , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  K. Hirao,et al.  Hepatocyte Growth Factor Ameliorates the Progression of Experimental Autoimmune Myocarditis: A Potential Role for Induction of T Helper 2 Cytokines , 2005, Circulation research.

[50]  M. Hanson,et al.  Hepatocyte Growth Factor/Scatter Factor Is an Axonal Chemoattractant and a Neurotrophic Factor for Spinal Motor Neurons , 1996, Neuron.

[51]  A. Sbarbati,et al.  Induction of neural-like differentiation in human mesenchymal stem cells derived from bone marrow, fat, spleen and thymus. , 2007, Bone.

[52]  C. Birchmeier,et al.  Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development , 1993, The Journal of cell biology.

[53]  Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo , 1992, Hepatology.

[54]  Z. Han,et al.  Cross‐talk between the VEGF‐A and HGF signalling pathways in endothelial cells , 2009, Biology of the cell.